Showing results (21-30 of 486) with videos related to
Sort By:
Pageof 49
International Journal of Hematology|October 31, 2012
Current and future management of follicular lymphomaGilles Salles, Hervé GhesquièresExpert Opinion on Investigational Drugs|July 24, 2020
Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphomaEstelle Bourbon, Gilles SallesHaematologica|May 30, 2024
Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?Paola Ghione, Gilles SallesHematological Oncology|June 9, 2023
CAR T-cell therapy in large B cell lymphomaAlexander P Boardman, Gilles SallesTherapeutic Advances in Hematology|June 9, 2021
The role of tazemetostat in relapsed/refractory follicular lymphomaGottfried von Keudell, Gilles SallesHaematologica|February 6, 2025
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironmentSary El Daker, David Qualls, Andriy Derkach, et al.Leukemia & Lymphoma|January 5, 2025
Advances in the treatment of high burden Follicular lymphoma: a Comprehensive reviewEfrat Luttwak, Anita Kumar, Gilles SallesTherapeutic Advances in Hematology|July 21, 2021
The use of tafasitamab in diffuse large B-cell lymphomaJohannes Düll, Max Topp, Gilles SallesExpert Review of Hematology|January 15, 2015
Chemotherapy-free treatment in patients with follicular lymphomaClémentine Sarkozy, Gilles Salles, Emmanuel BachyPageof 49